Discovery of TCMs and derivatives against the main protease of SARS-CoV-2 via high throughput screening, ADMET analysis, and inhibition assay in vitro

The rapidly evolving Coronavirus Disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide with thousands of deaths and infected cases. For the identification of effective treatments against this disease, the main protease (Mpro)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Qi, Xinyu (VerfasserIn) , Li, Binglin (VerfasserIn) , Omarini, Alejandra B. (VerfasserIn) , Gand, Martin (VerfasserIn) , Zhang, Xiaoli (VerfasserIn) , Wang, Jiao (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 July 2022
In: Journal of molecular structure
Year: 2022, Jahrgang: 1268, Pages: 1-14
ISSN:1872-8014
DOI:10.1016/j.molstruc.2022.133709
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.molstruc.2022.133709
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0022286022013643
Volltext
Verfasserangaben:Xinyu Qi, Binglin Li, Alejandra B. Omarini, Martin Gand, Xiaoli Zhang, Jiao Wang
Beschreibung
Zusammenfassung:The rapidly evolving Coronavirus Disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide with thousands of deaths and infected cases. For the identification of effective treatments against this disease, the main protease (Mpro) of SARS‑CoV‑2 was found to be an attractive drug target, as it played a central role in viral replication and transcription. Here, we report the results of high-throughput molecular docking with 1,045,468 ligands’ structures from 116 kinds of traditional Chinese medicine (TCM). Subsequently, 465 promising candidates were obtained, showing high binding affinities. The dynamic simulation, ADMET (absorption, distribution, metabolism, excretion and toxicity) and drug-likeness properties were further analyzed the screened docking results. Basing on these simulation results, 23 kinds of Chinese herbal extracts were employed to study their inhibitory activity for Mpro of SARS‑CoV‑2. Plants extracts from Forsythiae Fructus, Radix Puerariae, Radix astragali, Anemarrhenae Rhizoma showed acceptable inhibitory efficiencies, which were over 70%. The best candidate was Anemarrhenae Rhizoma, reaching 78.9%.
Beschreibung:Gesehen am 19.08.2022
Beschreibung:Online Resource
ISSN:1872-8014
DOI:10.1016/j.molstruc.2022.133709